M. Martinez et al., ALTERATIONS IN ERYTHROCYTE AGGREGABILITY IN DIABETICS - THE INFLUENCEOF PLASMATIC FIBRINOGEN AND PHOSPHOLIPIDS OF THE RED-BLOOD-CELL MEMBRANE, Clinical hemorheology and microcirculation, 18(4), 1998, pp. 253-258
In order to ascertain whether the increased aggregability observed in
the red blood cells of diabetic patients is induced exclusively by pla
sma factors or is also influenced by membrane lipids, we examined the
phospholipids of the erythrocyte membrane, the plasma fibrinogen conce
ntration and erythrocyte aggregation in 86 insulin and non insulin-dep
endent diabetic patients. The data obtained show that the erythrocyte
aggregability of the diabetic patients is higher than that of the cont
rol group (10.0 +/- 2.4 vs. 7.8 +/- 1.6%). This increased aggregabilit
y correlates not only with a higher fibrinogen concentration but also
with changes observed in the membrane phospholipids. The percentage of
sphingomyelin (SP) in the patients is higher than in the controls (22
.6 +/- 6.8 vs. 18.4 +/- 5.4%) and that of phosphatidylserine (PS) is l
ower (9.5 +/- 6.1 vs. 12.1 +/- 5.1%). No differences in the percentage
s of the other two phospholipids identified (phosphatidylcholine, PC,
and phosphatidylethanolamine, PE) were observed. The increase in the s
aturated nature of the phospholipids of the erythrocyte membrane, whic
h can be measured by the (SP + PC)/(PE + PS) ratio, is statistically r
elated (r = 0.39; p < 0.05) to the increased red blood cell aggregabil
ity observed in these patients.